|
Duloxetine vs. active comparator for the treatment of depression Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Duloxetine vs. active comparator for the treatment of depression conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Duloxetine vs. active comparator for the treatment of depression Clinical research trials and Duloxetine vs. active comparator for the treatment of depression medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Duloxetine vs. active comparator for the treatment of depression. Duloxetine vs. active comparator for the treatment of depression Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Duloxetine vs. active comparator for the treatment of depression clinical trial. Participants frequently obtain the most expert healthcare available for their Duloxetine vs. active comparator for the treatment of depression condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Duloxetine vs. active comparator for the treatment of depression  Duloxetine vs. active comparator for the treatment of depression
Duloxetine vs. active comparator for the treatment of depression
For Condition: Depression
Status: Recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: How duloxetine compares to a medication currently available for the treatment of depression in the treatment of patients with major depressive disorder. The safety of duloxetine and any side effects that might be associated with it.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - must be at least 18 years of age - must be diagnosed with depression - must sign informed consent Exclusion Criteria: - women who can become pregnant must be using birth control - previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder - history of substance abuse or dependence in the last year - patients who are suicidal - frequent or severe allergic reactions with multiple medications
Total Enrollment:
Location and Contact Information:
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Calgary, Alberta,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Sherbrooke, Quebec,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Halifax, Nova Scotia,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Ottawa, Ontario,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Victoria, British Columbia,
Canada
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician. *Recruiting*
Burlington, Ontario,
Canada
Recruiting
Additional Information:
Study ID Numbers: 7999;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00067912
Other Depression Studies:
1. Optimizing Electroconvulsive Therapy for Depression
2. Platelet Function in Patients Treated with SSRI and non-SSRI Antidepressants
3. Treatment of Depression in Youth with Bipolar Disorders
4. Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model
5. Treatment for Depression in the Primary Care Setting
Related Studies:
Other Depression Clinical Trials
Other Ontario Clinical Trials
Other Burlington Clinical Trials
Duloxetine vs. active comparator for the treatment of depression
|
|
|
|
|
|
|
|
